Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
eNq1mF1v2jAUhu/5FVHuSYDSQqdAtbF2Q2pVRos27QY5yaGYBTs9tvnYr59D6EYnR21NLXER4uQ9Jz6vHx85utgsM28FKChnPb8ZNHwPWMJTyh56/uT+qt71L/q1aEFW5OCxTtAImi3fSzIiRM8vRoMYCBPBj5vrz6DfB/T7NS/i8QIS+ew5JWkWfCVifkPy4hkvWnGaekuQc572/FzJ3V0vEhJ1Fv01x18iJwlE4f7O4ehi2j68H4WF2CtUlQC8JuzBKArMSjNRiMDkgEh44Lg1Ss+SaavbOWs0ulYhqBiD4AoTGBE5HyFf0RRScySSCbAKMlund4CrDGQRxCgeLpKlsBInC7IZw+PQnPRHPTqQG1lv1JudTrvRbnXa563TM6tQeDBVZvPojwjz6cnJSUv/QmAhXcaoVjQhdaovJGU0tqzTiKMkmaMKUTF47jVHcRAeX3RCSkWekW2wELntVBEkehhQE8HdhxRfcI+aUZmes//0mcqy8I1ZT/YEcZRxAagBV0xWgORqbDsRA84kbKorasc+udl7kYJ4P9nfnJm5P1JxRhNbvGkAKRByMh5W080VGD4RARN0R4bvlKV8Ld6fOIcVdpR9voOmUTTHtDltnXfPmqen1gvqp7ZTxc5zqZDnEGoWUXEMYoZsxo+Fi3aoWerJn06suWuJeEIyqGiK6pbM0Z586uGcud7diioHjKJfLu9trfJNAW7vdn+N0jTt/S2yHZBdUF4bszLxt9u8XO2vaJfbXctJUGiGyVzKXHwIw/V6HcyJqAuiJyuYoVPwH+y77hp3J5t72eyU8HSUelzuim+rlu3ie2n7P7al3b+/b52NMSQqOKIWJaed0XR4+f6A/tfPOkt79Awo7sLsek8iKWeu+iAVm5ugo7YEXVd2hRoQt7MZrThPqfRlFJZnOf1aFBbnOP3aH0i0+yU=
FBkj0aXPhWh19aDd
